Q-Line Biotech IPO
The Q-Line Biotech IPO was a ₹214.48 crore SME issue (fresh issue only), open for bidding from 21 May to 25 May 2026 at a price band of ₹326 to ₹343. The final issue price was ₹343. Investors bid for 42,62,45,600 shares through 2,35,655 applications. Shares listed on NSE SME on 29 May 2026 at ₹452.00, 31.8% above the issue price, and closed the first day at ₹474.60.
- Listing gain at open
- +31.8%₹452.00 vs ₹343
- Issue price
- ₹343Band ₹326 to ₹343
- Lot size
- 400 sharesMinimum ₹2,74,400
- Issue size
- ₹214.48 crore
- Subscribed
- Not available
- Listed
- 29 May 2026NSE SME
Price and lots
Q-Line Biotech IPO details
NSE issue details| Bidding dates | 21 May 2026 to 25 May 2026 |
| Listing date | 29 May 2026 |
| Price band | ₹326 to ₹343 |
| Final issue price | ₹343 |
| Face value | ₹10 per share |
| Lot size | 400 shares, minimum 2 lots for individuals |
| Minimum investment | ₹2,74,400 (800 shares, our calculation) |
| Issue size | ₹214.48 crore (our calculation from the NSE issue details) |
| Type of issue | 100 % Book Building, Fresh issue only |
| Listed on | NSE SME |
| NSE symbol | QLINE |
| ISIN | INE1G2W01011 |
| Lead managers | Hem Securities Limited, Share India Capital Services Private Limited |
| Registrar | Purva Sharegistry (India) Private Limited |
Subscription and listing
Q-Line Biotech IPO subscription and listing
NSE and BSEFinal subscription
NSE issue details| Category | Shares bid | Applications |
|---|---|---|
| QIBs | 14,72,37,200 | 197 |
| Non-institutional | 13,04,66,800 | 49,781 |
| Individual investors | 14,85,41,600 | 1,85,677 |
| Total | 42,62,45,600 | 2,35,655 |
For this SME issue NSE publishes shares bid and applications by category, not times subscribed.
Listing day
Our calculation: gains vs issue price| NSE | |
|---|---|
| Open | ₹452.00 |
| High | ₹474.60 |
| Low | ₹431.00 |
| Close | ₹474.60 |
| Gain at open | +31.8% |
| Gain at close | +38.4% |
| Shares traded | 36,73,600 |
Latest: closed at ₹511.70 on NSE on 6 November 2026, +49.2% vs the issue price (our calculation). Past returns say nothing about future returns.
How it compares
How the Q-Line Biotech IPO compares
Our calculation: 2026 SME IPOs on IPO24by7Among 78 SME IPOs of 2026 on our tracker, its listing gain of 31.8% at open ranks 12th of 75. By issue size it ranks 1st. The median listing-day gain at open for SME IPOs this year is +1.0%. See all 2026 IPOs with listing gains or the IPO calendar for May 2026.
Other SME IPOs listed in May 2026
| IPO | Listed | Issue price | Subscribed | Gain at open |
|---|---|---|---|---|
| Bio Medica Laboratories | 29 May 2026 | ₹139 | - | −20.0% |
| Teamtech Formwork Solutions | 26 May 2026 | ₹63 | - | +19.0% |
| NFP Sampoorna Foods | 25 May 2026 | ₹55 | - | −0.9% |
| RFBL Flexi Pack | 19 May 2026 | ₹50 | - | +5.0% |
| Simca Advertising | 15 May 2026 | ₹183 | - | −14.8% |
| Value 360 Communications | 11 May 2026 | ₹98 | - | −20.0% |
Allotment
Q-Line Biotech IPO allotment status
- Open the registrar's pagePurva Sharegistry (India) Private Limited is the registrar. Open its allotment page.
- Select Q-Line Biotech LimitedOlder issues may move to an archive list on the registrar's site.
- Enter your PAN, application number or DP IDUse the details you applied with.
- Or check your demat accountAllotted shares were credited before the listing day.
Documents
Questions
Q-Line Biotech IPO FAQs
What was the Q-Line Biotech IPO price band?
The price band was ₹326 to ₹343 per share and the final issue price was ₹343. The face value is ₹10 per share.
What was the Q-Line Biotech IPO lot size?
One lot was 400 shares. Individual investors had to apply for at least 2 lots, so the minimum was ₹2,74,400.
What was the Q-Line Biotech IPO listing price?
It opened at ₹452.00 on NSE SME on 29 May 2026, a gain of 31.8% over the issue price of ₹343 (our calculation). It closed the day at ₹474.60.
How do I check Q-Line Biotech IPO allotment status?
Purva Sharegistry (India) Private Limited is the registrar. Select Q-Line Biotech Limited on its allotment page and enter your PAN, application number or DP ID. You can also check on the NSE or BSE application status page.
Was the Q-Line Biotech IPO a fresh issue or an offer for sale?
Fresh issue only, as stated in the NSE issue details.
Who were the lead managers of the Q-Line Biotech IPO?
Hem Securities Limited, Share India Capital Services Private Limited.
Sources: NSE public issue information and IPO detail pages; NSE and BSE end-of-day bhavcopy files. Gains, issue size and minimum investment are our calculations. This page is information only, not a recommendation.